Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2025-12-24 @ 10:59 PM
NCT ID: NCT05464069
Eligibility Criteria: Inclusion Criteria: 1. Diagnosed with migraine 2. History of migraine pre-pregnancy with an average of at least 4 migraine days per month, in the six months prior to the last pregnancy 3. History of pregnancy with last menstrual period (LMP) between November 1st, 2019 - March 31st, 2021. Pregnancy within this time window is the pregnancy of study, termed "study pregnancy" 4. Between 18 and 42 years of age at first day of the last menstrual period (LMP) of "study pregnancy" 5. History of at least 4 migraine attacks during "study pregnancy" 6. In the study group: usage of Nerivio for at least 3 treatments (≥30 minutes/treatment) during "study pregnancy" 7. In the control group: No history of using Nerivio, ever Exclusion Criteria: 1. History of preterm birth (gestational age at deliver\<37 weeks) in previous pregnancies prior to the "study pregnancy" 2. History of congenital malformations or birth defects in previous pregnancies prior to the "study pregnancy" 3. Severe other diseases which started before the "study pregnancy" and lasted into the "study pregnancy" period, including congenital heart disease, arrhythmia, history of myocardial infarction (MI), history of stroke, or active cancer 4. Serious physical injury that occurred during the "study pregnancy": severe car collision injury, serious injury at home/work, etc. Multiple gestation (i.e., pregnancy with more than one baby at a time, such as pregnancy with twins, triplets, and quadruplets) in the "study pregnancy"
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 42 Years
Study: NCT05464069
Study Brief:
Protocol Section: NCT05464069